Charleston Laboratories
Charleston
About Charleston Laboratories
Charleston Laboratories, Inc is a specialty pharmaceutical company focused on the research and development of novel pain products that prevent or significantly reduce nausea and vomiting, the two most burdensome side effects related to opioid analgesics and other pain associated disease states. Charleston’s new products will address Opioid Induced Nausea and Vomiting (OINV), Postoperative Induced Nausea and Vomiting (PONV), Chemotherapy Induced Nausea and Vomiting (CINV), Radiation Induced Nausea and Vomiting (RINV) and Migraine Induced Nausea and Vomiting (MINV). In addition, Charleston is developing other products without acetaminophen to reduce the potential for liver injury and formulations with abuse deterrent technologies designed to curb misuse & abuse.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $7.4M
- Last round: Series Unknown (Oct 2012)
- Website: charlestonlabs.com
- Phone: 843-577-2626
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/charleston-laboratories-2739511 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.